These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29655584)

  • 1. Nanoemulsion adjuvant-driven redirection of T
    O'Konek JJ; Landers JJ; Janczak KW; Goel RR; Mondrusov AM; Wong PT; Baker JR
    J Allergy Clin Immunol; 2018 Jun; 141(6):2121-2131. PubMed ID: 29655584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens.
    Farazuddin M; Landers JJ; Janczak KW; Lindsey HK; Finkelman FD; Baker JR; O'Konek JJ
    Front Immunol; 2021; 12():599296. PubMed ID: 33717078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of allergen in a nanoemulsion adjuvant inhibits allergen-specific reactions in mouse models of allergic airway disease.
    Baker JR; Rasky AJ; Landers JJ; Janczak KW; Totten TD; Lukacs NW; O'Konek JJ
    Clin Exp Allergy; 2021 Oct; 51(10):1361-1373. PubMed ID: 33999457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.
    Smarr CB; Hsu CL; Byrne AJ; Miller SD; Bryce PJ
    J Immunol; 2011 Nov; 187(10):5090-8. PubMed ID: 21976774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal nanoemulsion vaccine confers long-lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy.
    O'Konek JJ; Landers JJ; Janczak KW; Lindsey HK; Mondrusov AM; Totten TD; Baker JR
    Allergy; 2020 Apr; 75(4):872-881. PubMed ID: 31557317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
    Int Immunol; 1999 Jul; 11(7):1131-8. PubMed ID: 10383946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice.
    Morafo V; Srivastava K; Huang CK; Kleiner G; Lee SY; Sampson HA; Li AM
    J Allergy Clin Immunol; 2003 May; 111(5):1122-8. PubMed ID: 12743580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization.
    van Wijk F; Hoeks S; Nierkens S; Koppelman SJ; van Kooten P; Boon L; Knippels LM; Pieters R
    J Immunol; 2005 Jan; 174(1):174-9. PubMed ID: 15611239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.
    Wavrin S; Bernard H; Wal JM; Adel-Patient K
    Int Arch Allergy Immunol; 2014; 164(3):189-99. PubMed ID: 25034179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy.
    Wiedermann U; Jahn-Schmid B; Repa A; Kraft D; Ebner C
    Int Arch Allergy Immunol; 1999; 118(2-4):129-32. PubMed ID: 10224359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.
    Strid J; Hourihane J; Kimber I; Callard R; Strobel S
    Clin Exp Allergy; 2005 Jun; 35(6):757-66. PubMed ID: 15969667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
    Takabayashi K; Libet L; Chisholm D; Zubeldia J; Horner AA
    J Immunol; 2003 Apr; 170(7):3898-905. PubMed ID: 12646659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression.
    Thottingal TB; Stefura BP; Simons FE; Bannon GA; Burks W; HayGlass KT;
    J Allergy Clin Immunol; 2006 Oct; 118(4):905-14. PubMed ID: 17030245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
    Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
    Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
    Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
    J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
    Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
    Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.